Montag, 5. September 2011

FDA approves gene-targeting lung cancer drug (AP)

AP - The Food and Drug Administration has approved a new Pfizer drug for a subset of lung cancer patients with a particular genetic mutation.

Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/ap/20110826/ap_on_he_me/us_pfizer_lung_cancer_drug

mesothelioma life expectancy mesothelioma prognosis

Keine Kommentare:

Kommentar veröffentlichen